Huijberts SCFA, Boelens MC, Bernards R, Opdam FL, et al. Mutational profiles associated with resistance in patients with BRAFV600E mutant
colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or
alpelisib. Br J Cancer 2020 Nov 18. pii: 10.1038/s41416-020-01147.
PMID: 33204026